| pubmed-article:1279644 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0038585 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0332256 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0013879 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0599740 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0205460 | lld:lifeskim |
| pubmed-article:1279644 | lifeskim:mentions | umls-concept:C0597191 | lld:lifeskim |
| pubmed-article:1279644 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1279644 | pubmed:dateCreated | 1992-12-7 | lld:pubmed |
| pubmed-article:1279644 | pubmed:abstractText | SP-antagonistic properties of a newly synthesized peptide Tyr-Pro-D-Phe-Phe-D-Phe-D-Trp-MetNH2 (AWL-60) were investigated both in vitro and in vivo. In vitro AWL-60 effectively antagonized the action of SP-agonist (SP6-11); however, this antagonism was non-competitive. Antagonistic properties of AWL-60 were also observed in vivo: in doses as low as 0.1 nmol/kg iv AWL-60 markedly attenuated the fall in blood pressure produced by [less than Glu]6SP6-11. Since AWL-60 exerts weak opioid agonistic properties (as a casomorphine analog) the possible involvement of an opioid agonistic component in their SP inhibitory action is considered. | lld:pubmed |
| pubmed-article:1279644 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1279644 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1279644 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1279644 | pubmed:issn | 0301-0244 | lld:pubmed |
| pubmed-article:1279644 | pubmed:author | pubmed-author:MisterekKK | lld:pubmed |
| pubmed-article:1279644 | pubmed:author | pubmed-author:LipkowskiA... | lld:pubmed |
| pubmed-article:1279644 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1279644 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:1279644 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1279644 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1279644 | pubmed:pagination | 25-32 | lld:pubmed |
| pubmed-article:1279644 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:meshHeading | pubmed-meshheading:1279644-... | lld:pubmed |
| pubmed-article:1279644 | pubmed:articleTitle | Bifunctional pharmacophores. Biological activities of the peptide analog containing both casomorphine-like and substance P antagonist-like active elements. | lld:pubmed |
| pubmed-article:1279644 | pubmed:affiliation | Department of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston 02114. | lld:pubmed |
| pubmed-article:1279644 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1279644 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1279644 | lld:pubmed |
